Posterior uveitis
MONDO:0006918Inflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis.
Also known as: chorioretinal region inflammation, inflammation of chorioretinal region
23 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New drug aims to tame eye inflammation in uveitis patients
Disease control Recruiting nowThis study tests a new drug, GenSci048, in people with active non-infectious uveitis, an inflammatory eye disease. The trial will compare two doses of GenSci048 against a placebo to see if it can control the disease and reduce treatment failure. About 111 adults with active uveit…
Phase: PHASE2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for uveitis: Anti-Inflammatory drug tested in chinese patients
Disease control Recruiting nowThis study tests the drug adalimumab (Tebiovio®) in 30 adults with non-infectious uveitis, an inflammatory eye disease. The goal is to see if the drug can control inflammation and prevent treatment failure. Participants will receive injections and be monitored for up to 24 weeks.…
Phase: PHASE4 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Eye injection shows promise for rare Fungal-Related blindness
Disease control Recruiting nowThis study tests whether faricimab (Vabysmo), an FDA-approved eye injection for other retinal diseases, can safely treat abnormal blood vessel growth in the eye caused by presumed ocular histoplasmosis syndrome. About 25 adults with this condition will receive an initial injectio…
Phase: PHASE4 • Sponsor: Cincinnati Eye Institute, Southwest Ohio • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Personalized immune cells take aim at Drug-Resistant eye virus
Disease control Recruiting nowThis study tests a new treatment called LB-DTK-CMV for people with cytomegalovirus (CMV) retinitis that has not responded to standard antiviral medicines. The treatment uses a patient's own immune cells, specially trained to attack CMV, and is given as two infusions. The trial ai…
Phase: NA • Sponsor: LucasBio • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New pill could tame eye inflammation without needles
Disease control Recruiting nowThis study tests an oral medication called FXS5626 in 40 adults with active non-infectious uveitis, a condition causing inflammation inside the eye. The goal is to see if the drug can control the disease better than a placebo, reducing the need for other treatments. Participants …
Phase: PHASE2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Head-to-head trial aims to find best way to save sight in IIH patients
Disease control Recruiting nowThis study compares two common procedures—CSF shunting and dural venous sinus stenting—to see which better preserves vision in adults with idiopathic intracranial hypertension (IIH) who are at risk of permanent sight loss. About 80 participants will be randomly assigned to one of…
Phase: NA • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New study aims to uncover uveitis patterns in kids
Knowledge-focused Recruiting nowThis study is observing 300 children under 18 with uveitis, an eye inflammation condition. Researchers want to learn how common different types of uveitis are and what treatments children receive. Participants have one visit with their doctor, and some will have their medical rec…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Researchers launch major study to unravel rare eye disease
Knowledge-focused Recruiting nowThis study follows 600 people with birdshot chorioretinopathy, a rare inflammatory eye disease, to better understand its features and causes. Researchers will use imaging, vision tests, and quality-of-life surveys to track the disease over time. They will also analyze DNA to find…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Scientists hunt for hidden triggers of autoimmune diseases
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from 300 people with autoimmune diseases like Crohn's, multiple sclerosis, and celiac disease. Researchers aim to identify the specific targets of immune cells (T cells) that cause inflammation. The goal is to discover new targets for …
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC